|
Cullinan Oncology Common
(CGEM)
|
21.5 |
$80M |
|
7.6M |
10.47 |
|
iTeos Therapeutics Common
|
15.1 |
$56M |
|
1.7M |
32.18 |
|
Merus Common
(MRUS)
|
6.5 |
$24M |
|
920k |
26.44 |
|
Repare Therapeutics Common
(RPTX)
|
6.3 |
$23M |
|
1.6M |
14.24 |
|
Harpoon Therapeutics Common
|
4.3 |
$16M |
|
3.2M |
4.97 |
|
Intellia Therapeutics Common
(NTLA)
|
3.1 |
$12M |
|
159k |
72.67 |
|
Werewolf Therapeutics Common
(HOWL)
|
2.8 |
$11M |
|
2.4M |
4.40 |
|
Biocryst Pharmaceuticals Common
(BCRX)
|
2.8 |
$10M |
|
639k |
16.26 |
|
Turning Point Therapeutics Common
|
2.5 |
$9.4M |
|
351k |
26.85 |
|
TCR2 Therapeutics Common
|
2.5 |
$9.3M |
|
3.4M |
2.76 |
|
Geron Corporation Common
(GERN)
|
2.2 |
$8.4M |
|
6.1M |
1.36 |
|
Cytokinetics Common
(CYTK)
|
2.2 |
$8.3M |
|
224k |
36.81 |
|
Crinetics Pharmaceuticals Common
(CRNX)
|
2.2 |
$8.0M |
|
367k |
21.95 |
|
Travere Therapeutics Common
(TVTX)
|
1.9 |
$7.2M |
|
278k |
25.77 |
|
Harmony Biosciences Hldgs Common
(HRMY)
|
1.8 |
$6.7M |
|
138k |
48.65 |
|
G1 Therapeutics Common
|
1.7 |
$6.5M |
|
857k |
7.60 |
|
Mirum Pharmaceuticals Common
(MIRM)
|
1.7 |
$6.4M |
|
289k |
22.02 |
|
Reata Pharmaceuticals inc-a Common
|
1.6 |
$5.9M |
|
180k |
32.76 |
|
YmAbs Therapeutics Common
|
1.4 |
$5.3M |
|
444k |
11.88 |
|
Arcutis Biotherapeutics Common
(ARQT)
|
1.3 |
$5.0M |
|
259k |
19.26 |
|
ADC Therapeutics Common
(ADCT)
|
1.3 |
$4.9M |
|
334k |
14.69 |
|
Amicus Therapeutics Common
(FOLD)
|
1.3 |
$4.7M |
|
496k |
9.47 |
|
Verastem Common
|
1.2 |
$4.6M |
|
3.2M |
1.41 |
|
Oncorus Common
|
1.1 |
$4.2M |
|
2.4M |
1.78 |
|
Axsome Therapeutics Common
(AXSM)
|
1.1 |
$4.1M |
|
100k |
41.39 |
|
ESSA Pharma Common
(EPIX)
|
1.1 |
$4.1M |
|
661k |
6.18 |
|
Epizyme Common
|
1.1 |
$3.9M |
|
3.4M |
1.15 |
|
Revolution Medicines Common
(RVMD)
|
1.0 |
$3.7M |
|
146k |
25.51 |
|
Relmada Therapeutics Common
(RLMD)
|
1.0 |
$3.7M |
|
138k |
26.99 |
|
Acadia Pharmaceuticals Common
(ACAD)
|
1.0 |
$3.7M |
|
152k |
24.22 |
|
Avadel Pharmaceuticals Adr
|
0.8 |
$2.8M |
|
412k |
6.83 |
|
Phathom Pharmaceuticals Common
(PHAT)
|
0.7 |
$2.6M |
|
193k |
13.61 |
|
Karuna Therapeutics Common
|
0.7 |
$2.5M |
|
20k |
126.80 |
|
Neogenomics Common
(NEO)
|
0.4 |
$1.6M |
|
136k |
12.15 |
|
Inozyme Pharma Common
(INZY)
|
0.3 |
$1.2M |
|
295k |
4.09 |
|
Avrobio Common
(AVRO)
|
0.2 |
$855k |
|
648k |
1.32 |
|
Black Diamond Therapeutics Common
(BDTX)
|
0.2 |
$664k |
|
240k |
2.77 |